Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NVS-PAK1-C (Synonyms: NVS-PAK1-C)

Catalog No. T35928 Copy Product Info
🥰Excellent
NVS-PAK1-1 is a potent allosteric inhibitor of PAK1 with an IC 50 of 5 nM for dephosphorylated PAK1 and 6 nM for phosphorylated PAK1 as assessed. Inhibition is ATP-competitive, most likely due to indirect competition due to incompatibility of ATP binding with the DFG-out binding conformation of the allosteric compound. NVS-PAK1-1 has an IC50 of 270 nM against dephosphorylated PAK2 and 720 nM against phosphorylated PAK2 respectively [1].

NVS-PAK1-C

Copy Product Info
🥰Excellent
Catalog No. T35928
Synonyms NVS-PAK1-C

NVS-PAK1-1 is a potent allosteric inhibitor of PAK1 with an IC 50 of 5 nM for dephosphorylated PAK1 and 6 nM for phosphorylated PAK1 as assessed. Inhibition is ATP-competitive, most likely due to indirect competition due to incompatibility of ATP binding with the DFG-out binding conformation of the allosteric compound. NVS-PAK1-1 has an IC50 of 270 nM against dephosphorylated PAK2 and 720 nM against phosphorylated PAK2 respectively [1].

NVS-PAK1-C
Cas No. 2250019-95-3
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$11335 days35 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
NVS-PAK1-1 is a potent allosteric inhibitor of PAK1 with an IC 50 of 5 nM for dephosphorylated PAK1 and 6 nM for phosphorylated PAK1 as assessed. Inhibition is ATP-competitive, most likely due to indirect competition due to incompatibility of ATP binding with the DFG-out binding conformation of the allosteric compound. NVS-PAK1-1 has an IC50 of 270 nM against dephosphorylated PAK2 and 720 nM against phosphorylated PAK2 respectively [1].
Targets&IC50
PAK1:5 nM, PAK1:0.007 μM (Kd), PAK2:270 nM, PAK2:0.4 μM (Kd)
In vitro
NVS-PAK1-1 potently inhibits PAK1 (S144) autophosphorylation at 0.25 μM in the Su86.86 cell line and MEK S289 phosphorylation with an IC 50 =0.21 μM in Su86.86 cells in which PAK2 is downregulated [1].
SynonymsNVS-PAK1-C
Chemical Properties
Molecular Weight465.9
FormulaC22H23ClF3N5O
Cas No.2250019-95-3
SmilesC(C(F)F)N1C=2C(C(N[C@@H]3CN(C(N(C)C)=O)CC3)=NC=4C1=CC=C(F)C4)=CC(Cl)=CC2
Relative Density.1.42 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (107.32 mM), Sonication is recommended.
DMF: 50 mg/mL (107.32 mM), Sonication is recommended.
Ethanol: 20 mg/mL (42.93 mM), Sonication is recommended.
DMSO:PBS(pH7.2) (1:1): 0.5 mg/mL (1.07 mM), Sonication is recommended.
Solution Preparation Table
Ethanol/DMSO/DMF
1mg5mg10mg50mg
5 mM0.4293 mL2.1464 mL4.2928 mL21.4638 mL
10 mM0.2146 mL1.0732 mL2.1464 mL10.7319 mL
20 mM0.1073 mL0.5366 mL1.0732 mL5.3660 mL
DMSO/DMF
1mg5mg10mg50mg
50 mM0.0429 mL0.2146 mL0.4293 mL2.1464 mL
100 mM0.0215 mL0.1073 mL0.2146 mL1.0732 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NVS-PAK1-C | purchase NVS-PAK1-C | NVS-PAK1-C cost | order NVS-PAK1-C | NVS-PAK1-C chemical structure | NVS-PAK1-C in vitro | NVS-PAK1-C formula | NVS-PAK1-C molecular weight